<SEC-DOCUMENT>0001104659-23-117439.txt : 20231114
<SEC-HEADER>0001104659-23-117439.hdr.sgml : 20231114
<ACCEPTANCE-DATETIME>20231113202036
ACCESSION NUMBER:		0001104659-23-117439
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20231113
FILED AS OF DATE:		20231114
DATE AS OF CHANGE:		20231113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BELITE BIO, INC
		CENTRAL INDEX KEY:			0001889109
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41359
		FILM NUMBER:		231401077

	BUSINESS ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-246-6240

	MAIL ADDRESS:	
		STREET 1:		12750 HIGH BLUFF DRIVE SUITE 475
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm2330526d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: bold 13.5pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 99.6pt; text-align: center">UNITED STATES</P>

<P STYLE="font: 13.5pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 99.6pt; text-align: center"><B>SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 99.6pt; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 13.5pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 99.6pt; text-align: center">FORM 6-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 194.15pt 0pt 195.65pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 194.15pt 0pt 195.65pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE
ISSUER PURSUANT TO RULE 13a-16 OR 15b-16 OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 99.6pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 99.6pt; text-align: center"><B>For the month of November
2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.35pt 0pt 101.45pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.35pt 0pt 101.45pt; text-align: center">Commission File Number: 001-41359</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Belite Bio, Inc</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.35pt 0pt 101.45pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.35pt 0pt 101.45pt; text-align: center">(Exact name of registrant
as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.35pt 0pt 101.45pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.35pt 0pt 101.45pt; text-align: center">(Translation of Registrant&acute;s
                             name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>12750 High Bluff Drive Suite 475,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>San Diego, CA 92130</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>(Address of principal
executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 101.45pt; text-align: center">Indicate by check mark whether
the registrant files or will file annual reports under cover Form 20-F or Form</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 101.45pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 101.45pt; text-align: center">40-F. Form 20-F <FONT STYLE="font-family: Wingdings">&#120;
</FONT>Form 40-F <FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Wingdings"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 103.4pt 0pt 101.45pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 86.1pt 0pt 84.15pt; text-align: center">Indicate by check mark if the
Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 86.1pt 0pt 84.15pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 86.1pt 0pt 84.15pt; text-align: center">101(b)(1): Yes <FONT STYLE="font-family: Wingdings">&#168;
</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No <FONT STYLE="font-family: Wingdings">&#120;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 86.1pt 0pt 84.15pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 86.1pt 0pt 84.15pt; text-align: center">Indicate by check mark if the
Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 86.1pt 0pt 84.15pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 86.1pt 0pt 84.15pt; text-align: center">101(b)(7): Yes <FONT STYLE="font-family: Wingdings">&#168;
</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No <FONT STYLE="font-family: Wingdings">&#120;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 86.1pt 0pt 84.15pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Indicate by check mark whether
the registrant by furnishing the information contained in this Form 6-K is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Yes <FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 13, 2023, Belite Bio, Inc issued a press release entitled
 &ldquo;Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results&rdquo;. A copy of this press release is attached
hereto as Exhibit 99.1 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Report on Form 6-K shall be deemed to be incorporated by reference
into all effective registration statements filed by the registrant under the Securities Act of 1933, and shall be a part thereof from
the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 276pt; text-align: justify"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif"><A HREF="tm2330526d1_ex99-1.htm">Exhibit 99.1 &mdash; Press Release</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0000EE">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 276pt; text-align: justify"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD>
    <TD COLSPAN="2"><B>Belite Bio, Inc</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Yu-Hsin Lin</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Yu-Hsin Lin</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer and Chairman</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: November 13, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2330526d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

                        <P STYLE="margin: 0"></P>



<P STYLE="margin: 0"></P>

<P STYLE="text-align: right; margin: 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Belite Bio Reports Third Quarter 2023 Operational
Highlights and Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.15pt"></TD><TD STYLE="width: 10.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="padding-right: 15pt">Completed enrollment in pivotal Phase 3 &ldquo;DRAGON&rdquo; trial for Tinlarebant in adolescent Stargardt
disease (&ldquo;STGD1&rdquo;) with 104 subjects enrolled across 11 countries worldwide</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 15.15pt"></TD><TD STYLE="width: 10.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>First subject dosed with Tinlarebant in pivotal global Phase 3 &ldquo;PHOENIX&rdquo; trial in Geographic Atrophy (&ldquo;GA&rdquo;)</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 15.15pt"></TD><TD STYLE="width: 10.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="padding-right: 11pt">Oral, once-daily Tinlarebant continues to be safe and well tolerated, slowing expansion of autofluorescence,
reducing incident atrophic retinal lesion growth rate, and stabilizing visual acuity up to 24-months in Phase 2 STGD1 trial (&ldquo;LBS-008-CT02&rdquo;)</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 15.15pt"></TD><TD STYLE="width: 10.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="padding-right: 11pt">Interim Phase 3 safety and efficacy data from pivotal &ldquo;DRAGON&rdquo; trial expected in 2H 2024</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 15.15pt"></TD><TD STYLE="width: 10.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Conference Call and Webcast Tuesday, November 14, 2023, at 4:30 p.m. ET</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0"><B>SAN DIEGO, November 13, 2023</B>- Belite Bio, Inc (NASDAQ:
BLTE) (&ldquo;Belite&rdquo; or the &ldquo;Company&rdquo;), a clinical-stage biopharmaceutical drug development company focused on advancing
novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its financial results
for the three-months ended September 30, 2023, and provided a general business update.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0">&ldquo;We made meaningful progress in the quarter advancing
our clinical trials for Tinlarebant and are excited by our results,&rdquo; said Dr. Tom Lin, Chairman and CEO of Belite Bio. &ldquo;Results
from our Phase 2 trial of Tinlarebant in childhood-onset Stargardt Disease showed Tinlarebant lowered retinal lesion growth versus patients
in a 24-month natural history study and visual acuity was stabilized, all while remaining safe and well-tolerated. Additionally, in the
quarter, we completed enrollment for the DRAGON trial, dosed our first subject and made substantial progress in the PHOENIX trial. We
remain focused on our vision to bring novel therapies to patients suffering from degenerative retinal diseases.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0">Professor John Grigg, Head Specialty of Ophthalmology at the
University of Sydney and Consultant Ophthalmologist at the Sydney Children&rsquo;s Hospitals Network at Westmead and Sydney Eye Hospital,
presented the results of the Phase 2 trial of Tinlarebant in adolescent Stargardt disease patients at the American Association of Ophthalmology
annual meeting early this month and commented, &ldquo;The results of the Phase 2 study with 24-month treatment of Tinlarebant in adolescents
were promising. Stargardt is a debilitating disease that may have a life-changing impact on those diagnosed with the disease. The disease
most often progresses quickly, and vision deteriorates rapidly at a very young age. The Phase 2 data continued to demonstrate slowing
of the disease progression in the study cohort and the stabilization in several structural and functional parameters including stabilization
of visual acuity. We are highly encouraged by these results and the potential to impact the lives of patients suffering from a disease
for which there currently is no FDA-approved treatment.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Third Quarter 2023 Business Highlights and Upcoming Milestones:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Clinical Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 16pt 0pt 0"><B>Tinlarebant </B>(LBS-008) is designed to be an oral, potent,
once-daily retinol binding protein 4 (RBP4) antagonist that decreases RBP4 levels in the blood and reduces vitamin A (retinol) delivery
to the eye without disrupting systemic retinol delivery to other tissues. Vitamin A is critical to normal vision but can accumulate as
toxic byproducts leading to retinal cell death and vision loss diseases such as STGD1 and GA, the advanced form of dry Age-Related Macular
Degeneration (dry AMD).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 16pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.95pt"></TD><TD STYLE="width: 14.05pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="padding-right: 7pt"><B>Stargardt disease (STGD1): </B>Accumulation of cytotoxic bisretinoids has been implicated in the onset
and progression of STGD1. Tinlarebant has been granted Fast Track and Rare Pediatric Disease (RPD) designations by the U.S. Food and Drug
Administration (FDA), and orphan drug designation (ODD) in the U.S. and Europe for STGD1. There are currently no FDA-approved treatments
for STGD1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 16pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.15pt"></TD><TD STYLE="width: 13.85pt">o</TD><TD>LBS-008-CT02 trial: Ongoing, open-label, 2-year Phase 1b/2 trial in adolescent STGD1 subjects</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.2pt"></TD><TD STYLE="width: 11.8pt">&sect;</TD><TD>A total of 12 adolescent STGD1 subjects aged 12-18 years completed 24-months of treatment in the Phase 2 study of Tinlarebant. Key
study findings are as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 79.4pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Tinlarebant was safe and well-tolerated with no withdrawals due to adverse events.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 79.4pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Retinal imaging showed that 5 of 12 subjects remained free of atrophic retinal lesions (referred to as definitely decreased autofluorescence
or DDAF) after 24 months of Tinlarebant treatment.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 79.4pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>A comparison of the 24-month DDAF lesion growth between Tinlarebant-treated subjects and ProgStar participants possessing similar
baseline characteristics (aged &le;18 years) showed a sustained lower DDAF lesion growth in Tinlarebant-treated subjects over the 24-month
treatment period (p&lt;0.001).</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 79.4pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Visual acuity was stabilized in the majority of subjects during the study with a mean loss of five letters following 24 months of
treatment (a loss of &lt;10 letters is not considered clinically significant).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 301px; width: 569px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 31.5pt"><FONT STYLE="font-size: 10pt"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 122px; width: 526px"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 88.8pt; text-indent: -3.3pt"><I>*Only 50 patients from ProgStar
Cohort (aged &le;18 ) were included in the analysis due to one subject having ungradable screening FAF data.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 88.8pt; text-indent: -3.3pt"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><I>1.</I></TD><TD><I>Strauss RW, Ho A, Mu&ntilde;oz B, et al. ProgStar Report No. 1. Ophthalmology. 2016;123(4):817-28.</I></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><I>2.</I></TD><TD><I>Strauss RW, Mu&ntilde;oz B, Ho A, et al. ProgStar Report No. 9. JAMA Ophthalmol. 2017; 135(11):1232-1241. </I></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.15pt"></TD><TD STYLE="width: 13.85pt">o</TD><TD STYLE="padding-right: 1pt">Pivotal DRAGON trial: 2-year, randomized, double-masked, placebo-controlled, global, multi-center, pivotal
Phase 3 trial in STGD1 subjects aged 12-20 years old:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.2pt"></TD><TD STYLE="width: 11.8pt">&sect;</TD><TD>Enrollment complete, with 104&nbsp;subjects across 11 countries worldwide including sites in the U.S., the United Kingdom, Germany,
Belgium, France, Switzerland, China, Hong Kong, Taiwan, Australia, and the Netherlands.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.2pt"></TD><TD STYLE="width: 11.8pt">&sect;</TD><TD>Primary efficacy endpoint is slowing of lesion growth rate; safety and tolerability will also be assessed.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.2pt"></TD><TD STYLE="width: 11.8pt">&sect;</TD><TD>2H 2024: Interim efficacy and safety data expected.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.15pt"></TD><TD STYLE="width: 14.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Geographic Atrophy (GA)</B>: GA, the advanced form of dry AMD, is a chronic degenerative disease of
the retina that leads to blindness in the elderly. Accumulation of toxic vitamin A byproducts (bisretinoids) has been implicated in the
progression of GA. There are currently no FDA-approved orally administered treatments for GA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 41.15pt"></TD><TD STYLE="width: 13.85pt">o</TD><TD STYLE="padding-right: 1pt">Pivotal PHOENIX Trial: 2-year prospective, randomized (2:1, active:placebo, n ~430), double-masked, placebo-controlled,
global, multi-center, Phase 3 trial in subjects with GA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.2pt"></TD><TD STYLE="width: 11.8pt">&sect;</TD><TD>Primary efficacy endpoint is slowing of lesion growth rate; safety and tolerability will also be assessed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.2pt"></TD><TD STYLE="width: 11.8pt">&sect;</TD><TD>First subject has been dosed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.2pt"></TD><TD STYLE="width: 11.8pt">&sect;</TD><TD>Interim analysis expected at mid-point of the trial.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="padding-right: 15pt">For the three months ended September 30, 2023<FONT STYLE="font-family: Times New Roman, Times, Serif">,</FONT>
the Company strengthened its balance sheet with $5.0 million of gross proceeds from the exercise of warrants granted in the underwritten
follow-on offering in May 2023.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="padding-right: 15pt">For the three months ended September 30, 2023, the Company raised $0.64 million of net proceeds from its
at-the-market offering program established in June 2023.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks and Uncertainties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26pt">Based on current business plans and financial expectations,
the Company expects that it will be a &ldquo;passive foreign investment company&rdquo; within the meaning of Section 1297 of the U.S.
Internal Revenue Code of 1986, as amended (&ldquo;PFIC&rdquo;) for its current tax year 2023, and may be a PFIC in one or more future
tax years, which may have adverse U.S. federal income tax consequences for U.S. securityholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26pt">If the Company is a PFIC for any year during a U.S. taxpayer&rsquo;s
holding period of the Company&rsquo;s ADSs or ordinary shares, then such U.S. taxpayer generally will be required to treat any gain realized
upon a disposition of the Company&rsquo;s ADSs, ordinary shares or warrants or any so-called &ldquo;excess distribution&rdquo; received
on such ADSs, ordinary shares or warrants as ordinary income, and to pay an interest charge on a portion of such gain or distribution.
In certain circumstances, the sum of the tax and the interest charge may exceed the total amount of proceeds realized on the disposition,
or the amount of excess distribution received, by the U.S. taxpayer. Subject to certain limitations, these tax consequences may be mitigated
if a U.S. taxpayer makes a timely and effective &ldquo;qualified electing fund&rdquo; (&ldquo;QEF&rdquo;) election within the meaning
of Section 1295 of the Code (a &ldquo;QEF Election&rdquo;) or a &ldquo;mark-to-market election&rdquo; within the meaning of Section 1296
of the Code (a &ldquo;Mark-to-Market Election&rdquo;). The QEF Election is not available with respect to warrants until those warrants
are exercised. Each investor in a warrant (and, in particular, any such investor that holds warrants but not ADSs or ordinary shares)
who is a U.S. taxpayer should consult its own tax advisor regarding the tax consequences of the PFIC rules and the ownership and disposition
of the warrants. The Mark-to-Market Election is only available with respect to ADSs, ordinary shares or warrants regularly traded on
a qualified exchange or market. Subject to certain additional limitations, such elections may be made with respect to the Company&rsquo;s
ADSs or ordinary shares (and with respect to the Mark-to-Market Election, the warrants). A U.S. taxpayer who makes a timely and effective
QEF Election generally must report on a current basis its share of the Company&rsquo;s net capital gain and ordinary earnings for any
year in which the Company is a PFIC, whether or not the Company distributes any amounts with respect to the ADSs or ordinary shares.
However, U.S. taxpayers should be aware that there can be no assurance that the Company will satisfy the record keeping requirements
that apply to a QEF, or that the Company will supply U.S. taxpayers with information that such U.S. taxpayers require to report under
the QEF Election rules, in the event that the Company is a PFIC and a U.S. taxpayer wishes to make a QEF Election. Thus, U.S. taxpayers
may not be able to make a QEF Election with respect to their ADSs or ordinary shares. A U.S. taxpayer who makes the Mark-to-Market Election
generally must include as ordinary income each year the excess of the fair market value of the ADSs or ordinary shares over the taxpayer&rsquo;s
basis therein. Each potential investor who is a U.S. taxpayer should consult its own tax advisor regarding the tax consequences of the
PFIC rules and the ownership and disposition of ADSs or ordinary shares, including the availability of and procedure for making a QEF
Election or a Mark-to-Market Election.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Third Quarter 2023 Financial Results:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cash: </B>As of September 30, 2023, the Company had $54.5 million
in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>R&amp;D Expenses:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6pt 0pt 0">For the three months ended September 30, 2023, research and
development expenses were $8.7 million compared to $1.2 million for the same period in 2022. The increase resulted primarily from increases
in (x) expenses for conducting the DRAGON and PHOENIX trials and (y) wages and salaries due to share-based compensation granted to our
R&amp;D team in the third quarter of 2023. For the nine months ended September 30, 2023, research and development expenses were $20.0
million compared to $3.6 million for the same period in 2022. The increase in research and development expenses was primarily attributable
to increases in (i) expenses related to conducting the DRAGON and PHOENIX trials, and (ii) wages and salaries due to our R&amp;D team
expansion and share-based compensation granted in the third quarter of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>G&amp;A Expenses:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0">For the three months ended September 30, 2023, general and
administration expenses were $2.2 million compared to $1.4 million for the same period in 2022. The increase resulted primarily from an
increase in share-based compensation granted in the third quarter of 2023. For the nine months ended September 30, 2023, general and administration
expenses were $4.7 million compared to $2.5 million for the same period in 2022. The increase resulted also primarily from an increase
in share-based compensation granted in the third quarter of 2023 and an increase in professional service fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><IMG SRC="image_003.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Net Loss:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0">For the three months ended September 30, 2023, the Company
reported a net loss of $10.9 million or ($0.40) per share compared to $2.4 million or ($0.10) per share for the same period in 2022. For
the nine months ended September 30, 2023, the Company reported a net loss of $24.6 million or ($0.95) per share, compared to a net loss
of $5.9 million or ($0.32) per share for the same period in 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Webcast Information</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0; text-align: justify">Belite Bio will host a webcast on Tuesday,
November 14, 2023, at 4:30 p.m. Eastern Time to discuss the Company&rsquo;s financial results and provide a business update. To join the
webcast, please visit https://wsw.com/webcast/cc/blte/1366794. A replay will be available for approximately 90 days following the event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Belite Bio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0">Belite Bio is a clinical-stage biopharmaceutical drug development
company focused on advancing novel therapeutics targeting degenerative retinal diseases with significant unmet medical needs, such as
STGD1 and GA in advanced dry AMD, in addition to specific metabolic diseases. For more information, follow us on <U>Twitter</U>, <U>Instagram</U>,
<U>LinkedIn</U>, <U>Facebook</U> or visit us at <U>www.belitebio.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Important Cautions Regarding Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>This press release contains forward-looking statements about future
expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts. These statements
include but are not limited to statements regarding the potential implications of clinical data for patients, clinical development, regulatory
milestones of its product candidates, and any other statements containing the words &ldquo;expect&rdquo;, &ldquo;will&rdquo;, &ldquo;believe&rdquo;,
and other similar expressions. Actual results may differ materially from those indicated in the forward-looking statements as a result
of various important factors, including but not limited to Belite Bio&rsquo;s ability to demonstrate the safety and efficacy of its drug
candidates; the clinical results for its drug candidates, which may not support further development or regulatory approval; expectations
for the timing of initiation, enrollment and completion of, and data relating to, its clinical trials; the content and timing of decisions
made by the relevant regulatory authorities regarding regulatory approval of Belite Bio&rsquo;s drug candidates; whether additional clinical
trials may be required for DRAGON or PHOENIX studies based on their respective data; the potential efficacy of Tinlarebant, as well as
those risks more fully discussed in the &ldquo;Risk Factors&rdquo; section in Belite Bio&rsquo;s filings with the U.S. Securities and
Exchange Commission. All forward-looking statements are based on information currently available to Belite Bio, and Belite Bio undertakes
no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise,
except as may be required by law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;<IMG SRC="image_003.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BELITE BIO, INC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS AND COMPREHENSIVE LOSS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in thousands of US Dollars, except
share and per share amounts)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">For the Three Months</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">For the Nine Months</TD>
    <TD STYLE="text-align: left; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Ended September 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Ended September 30,</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD>
    <TD STYLE="text-align: left; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold">Expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 35%; font-size: 10pt; text-align: left">Research and development</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,185</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">8,743</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">3,643</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">19,982</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">General and administrative</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,355</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,218</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,457</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">4,731</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,540</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">10,961</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6,100</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">24,713</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Loss from operations</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,540</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(10,961</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(6,100</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(24,713</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Other income (expense):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Total other income, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">137</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">27</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">236</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">81</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Loss before income tax</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,403</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(10,934</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(5,864</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(24,632</TD>
    <TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Income tax expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">10</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Net loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,403</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(10,935</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(5,864</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(24,642</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Other comprehensive income (loss)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Foreign currency translation adjustments, net of nil tax</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(166</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(55</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(323</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(115</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total comprehensive loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,569</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(10,990</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(6,187</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(24,757</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold">Weighted average number of ordinary shares used in per share calculation:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">- Basic and Diluted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">24,869,038</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">27,315,550</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,321,088</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">26,013,012</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold">Net loss per ordinary share</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">- Basic and Diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.10</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.40</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.32</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.95</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="image_003.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BELITE BIO, INC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in thousands of US Dollars, except
share amounts)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 72%; font-size: 10pt; text-align: left">Current assets</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">42,807</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">56,135</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,466</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,463</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">44,273</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">57,598</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">TOTAL LIABILITIES</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2,772</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">4,804</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">TOTAL SHAREHOLDERS&rsquo; EQUITY</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">41,501</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">52,794</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">TOTAL LIABILITIES AND SHAREHOLDERS&rsquo; EQUITY</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">44,273</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">57,598</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">Ordinary shares authorized</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">492,179,086</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">400,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Ordinary shares issued and outstanding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">24,898,908</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">27,599,244</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media and Investor Relations Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Jennifer Wu </B><U>/ir@belitebio.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Argot Partners /</B><U>belitebio@argotpartners.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U></U></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U></U></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %X L@# 2(  A$! Q$!_\0
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M[J>A2/\ <&H6KQ!OH2,'\#5>VKVO=V,O[-RWFY/9QOVTO]Q[9_PWQ\6_^?\
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M'B/3GTO46@2Y$#NCGRW&5;*DCGZYH]O6M?F8?V7EZ:BZ4;OR1[9_PWQ\6_\
MG_T[_P !G_\ CE'_  WQ\6_^?_3O_ 9__CE?.E%+ZQ5_F97]DX#_ )\Q^X^B
M_P#AOCXM_P#/_IW_ (#/_P#'*/\ AOCXM_\ /_IW_@,__P <KYTJ:6SN((8I
MI;>:*&;)BEDC94DQUVDC!_"G]8J_S,7]DX#_ )\Q^X^A?^&^/BW_ ,_^G?\
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MKEK&_E/-I]H\R*^,[25'7!''O3]M6O;F9+RW+5'G=*-N^ECV;_AOCXM_\_\
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MI48EO[JVA+QVJ$$AI&'W1A6Z^AK(H]O6_F8EE>7MM*E'3R/HO_AOCXM_\_\
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M_IW_ (#/_P#'*^=**/K%7^9A_9. _P"?,?N/HO\ X;X^+?\ S_Z=_P" S_\
MQRC_ (;X^+?_ #_Z=_X#/_\ '*^=**/K%7^9A_9. _Y\Q^X^B_\ AOCXM_\
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MU'Q!;MX:^*W[*?@_4-H\1Z+!;G4(<YDM_-D0I$_H1M/'M7S5^T9_R7_XC?\
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MC_A@GXS_ /0M6_\ X,[;_P".4>QJ_P K^X/[2P7_ #^C_P"!+_,^>:*^AO\
MA@GXS_\ 0M6__@SMO_CE'_#!/QG_ .A:M_\ P9VW_P <H]C5_E?W!_:6"_Y_
M1_\  E_F?/-%?0W_  P3\9_^A:M__!G;?_'*/^&"?C/_ -"U;_\ @SMO_CE'
ML:O\K^X/[2P7_/Z/_@2_S/GFBOH;_A@GXS_]"U;_ /@SMO\ XY1_PP3\9_\
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M1O9FN+FYDQNED8Y9CCN37O/_  P3\9_^A:M__!G;?_'*/^&"?C/_ -"U;_\
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MH_ 55U3QOKVM>&=(\.WVJ3W.AZ07:PL&P(K<N26*@#J<GDYZU[5_PP3\9_\
MH6K?_P &=M_\<H_X8)^,_P#T+5O_ .#.V_\ CE'LJS^RQK&Y=%)*K"RVUCIZ
M'AGAKQ-JO@W7;36M#OYM,U6T8O!=P$!XR00<9]B1^-:5]\2O%&I:'JNCW.M7
M$VEZI?'4KVT(4)/<DY,K8'WLCMQ7L/\ PP3\9_\ H6K?_P &=M_\<H_X8)^,
M_P#T+5O_ .#.V_\ CE+V59*W*QO'9?)\SJPOZH^>:OZ#KVH^%]:LM7TF[DL-
M3LI!-;W46-\3CHPR.M>[_P##!/QG_P"A:M__  9VW_QRC_A@GXS_ /0M6_\
MX,[;_P".4O8U?Y64\QP,E9UH_P#@2/!=:UB]\1ZM>ZIJ=R][J%[*T]S<2XW2
MR,<LQ]R:V]:^)_BSQ'HNB:3J?B"]O;#1,'38Y7&ZTP !Y;@;AP!W[#T%>O\
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M7(32O/-)+(Q>21B[L>I8G)/YFOH/_A@GXS_]"U;_ /@SMO\ XY1_PP3\9_\
MH6K?_P &=M_\<J72K/>+-(X[+X?#5@NFZ/,_!/QT\?\ PWT=M*\,>*[_ $33
MFE:<VUL4VF1@ 6Y4\D ?E4OC'X^_$7X@Z%+HOB3Q=J&L:5*RN]I<%-C,IRI.
M%'0UZ/\ \,$_&?\ Z%JW_P#!G;?_ !RC_A@GXS_]"U;_ /@SMO\ XY5>SKVM
M9V^9E]:ROG]IST^;O>-_O.*\*_M0_%7P3HL6DZ1XVU&#3H4\N*"81S^4OHID
M4D8[<\5EZ+\>OB+X?\47_B.P\9:M#K6H!1>7;3>8;@+PH=6!5@H) &.,\8KT
MG_A@GXS_ /0M6_\ X,[;_P".4?\ #!/QG_Z%JW_\&=M_\<HY*^FC_$7UC*M7
MS4]=_AU]>YYA\1_C;XY^+BVT?BWQ)=ZQ;VYW16S[8X4;&-VQ %+>Y&:Q/%'C
MGQ!XVU2UU+7=6N=2U"U@CMH+F5@'CC3)15*@8P2<=Z]J_P"&"?C/_P!"U;_^
M#.V_^.4?\,$_&?\ Z%JW_P#!G;?_ !RDZ=9[IFD,9EM-)0J05MK..AQ]Y^U7
M\6[[PZVAS^.]3>P:/RG(V+,R8QM,H7?C'OGWK@_#OC77?"-KJ]MHVJ3Z?!J]
ML;._CAQBYA.<HV0>.3T]:]L_X8)^,_\ T+5O_P"#.V_^.4?\,$_&?_H6K?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"GENRG.[S3P#F+N*^E/@_;-9_#7086M?#=BR0$&W\'G.E)\S<6YVK\GX#G-
M'8U\V_MO7&AP^!]%%QI<M_XB_MG3)K.6UTF:\GBMXM1M9;DJ\<;&,!$W'D;@
MO>OI*B@#R3XF>.-<\8>"=;T7X8K+)XONM*M[RSN;Z&:SACM[ARAD29X]HF5!
M(P0C(8)N !KS[]C7PSKG@OQ!\6='O? R^#='BUNV-DBWPN5?;IUJC;6V+YF=
MNYI>[NX/*DU].44 1S+(RXC<(V>K+FJENUW.KGSHQM=E_P!7Z''K5^JNG_ZN
M;_KJ_P#.@ \JZ_Y^(_\ OW_]>CRKK_GXC_[]_P#UZM44 5?*NO\ GXC_ ._?
M_P!>CRKK_GXC_P"_?_UZM44 5?*NO^?B/_OW_P#7H\JZ_P"?B/\ []__ %ZM
M44 5?*NO^?B/_OW_ /7H\JZ_Y^(_^_?_ ->K5% %7RKK_GXC_P"_?_UZ/*NO
M^?B/_OW_ /7JU10!5\JZ_P"?B/\ []__ %Z/*NO^?B/_ +]__7JU10!5\JZ_
MY^(_^_?_ ->CRKK_ )^(_P#OW_\ 7JU10!5\JZ_Y^(_^_?\ ]>CRKK_GXC_[
M]_\ UZM44 5?*NO^?B/_ +]__7H\JZ_Y^(_^_?\ ]>K5% %7RKK_ )^(_P#O
MW_\ 7H\JZ_Y^(_\ OW_]>K5% %7RKK_GXC_[]_\ UZ/*NO\ GXC_ ._?_P!>
MK5% %7RKK_GXC_[]_P#UZ/*NO^?B/_OW_P#7JU10!5\JZ_Y^(_\ OW_]>CRK
MK_GXC_[]_P#UZM44 5?*NO\ GXC_ ._?_P!>CRKK_GXC_P"_?_UZM44 5?*N
MO^?B/_OW_P#7H\JZ_P"?B/\ []__ %ZM44 5?*NO^?B/_OW_ /7H\JZ_Y^(_
M^_?_ ->K5% %7RKK_GXC_P"_?_UZ/*NO^?B/_OW_ /7JU10!5\JZ_P"?B/\
M[]__ %Z/*NO^?B/_ +]__7JU10!5\JZ_Y^(_^_?_ ->CRKK_ )^(_P#OW_\
M7JU10!5\JZ_Y^(_^_?\ ]>CRKK_GXC_[]_\ UZM44 5?*NO^?B/_ +]__7H\
MJZ_Y^(_^_?\ ]>K5% %7RKK_ )^(_P#OW_\ 7H\JZ_Y^(_\ OW_]>K5% %7R
MKK_GXC_[]_\ UZ/*NO\ GXC_ ._?_P!>K5% %7RKK_GXC_[]_P#UZ/*NO^?B
M/_OW_P#7JU10!5\JZ_Y^(_\ OW_]>CRKK_GXC_[]_P#UZM44 5?*NO\ GXC_
M ._?_P!>CRKK_GXC_P"_?_UZM44 5?*NO^?B/_OW_P#7H\JZ_P"?B/\ []__
M %ZM44 5?*NO^?B/_OW_ /7H\JZ_Y^(_^_?_ ->K5% %7RKK_GXC_P"_?_UZ
M/*NO^?B/_OW_ /7JU10!5\JZ_P"?B/\ []__ %Z/*NO^?B/_ +]__7JU10!5
M\JZ_Y^(_^_?_ ->CRKK_ )^(_P#OW_\ 7JU10!5\JZ_Y^(_^_?\ ]>CRKK_G
MXC_[]_\ UZM44 5?*NO^?B/_ +]__7H\JZ_Y^(_^_?\ ]>K5% %7RKK_ )^(
M_P#OW_\ 7H\JZ_Y^(_\ OW_]>K5% %7RKK_GXC_[]_\ UZ/*NO\ GXC_ ._?
M_P!>K5% #(E=4Q(P=O4#%/HHH **\Z^,W[0'@;X!^#!XG\8ZU'9:;)/]EMU@
M0SS74_/[J)$R6;Y3],'.*S?@1^T[X!_:,M]6_P"$/U&X:_TB41:AI6I6KVMY
M:EL[2\3C.#@X(R.".M 'J]%>2_';]J/X?_LZ#28?%VHW/]J:NS+8:1IEH]W>
M7(7&YEB09VC/4X]LU2T7]L+X3:Y\%;WXJP^*X(?!UBY@N[BXC=)K>?('D/#C
M?YA++A0#G<",CF@#V>BO$/@9^V/\,OVA-:U#1?#&I7EMKEC;B\DTO6;*2SN&
MMSC$R*X^9/F7D'C([$59^'G[7GPN^+'Q:O\ X=^#_$2^(M<L;%M0FN-/3S;(
M1JR*RB<?*S NO ]_0T >E:#_ ,A?7_\ KZ3_ -%)11H/_(7U_P#Z^D_]%)10
M!)X/_P"19TW_ *XBMBL?P?\ \BSIO_7$5JS3);PR2R';'&I9CC. !DT ?('[
M65]H$OQ8L]/\1R?!OPI NDQSVVN?%#0HM1EU$F617A@9YHMBPX4D$L29P0!@
MY^AO@6MBOPE\-#3+_P ,ZG8?9SY-WX.M%M=)D&]N;>)7<(G; 8\@UXIXTMKC
MQ]\2)O'WPV^(GPMDL;S2H-*N(_$E@=2</!+,_P K)<QF/'FD%,=1R,XQ[/\
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M]I6_]\_]\-_A0!:HJK_:5O\ WS_WPW^%']I6_P#?/_?#?X4 6J*J_P!I6_\
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M92JX'3 XI/!L?@S7O Z67ABWT>[\)#SK%;33X8_L6$=HY8A&HVX#JZD8QP:
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M]]10 55T_P#U<W_75_YU:JKI_P#JYO\ KJ_\Z +5%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,=JDXS]*6B@#!\&^+5
M\9:;->+I.JZ-Y4[0&WUBV^SS';CY@N3\ISP>];U<+\-18C7/'WV.>XFE.OM]
MI6= HCE^S6_RI@G*[=IR<')/'%=U52T>@EL%%%%2,\E_:H\1>-_#GP+\3O\
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MG_Y^V_[X7_"@"S15;[//_P _;?\ ?"_X4?9Y_P#G[;_OA?\ "@"S15;[//\
M\_;?]\+_ (4?9Y_^?MO^^%_PH LT56^SS_\ /VW_ 'PO^%'V>?\ Y^V_[X7_
M  H LT56^SS_ //VW_?"_P"%'V>?_G[;_OA?\* +-%5OL\__ #]M_P!\+_A1
M]GG_ .?MO^^%_P * +-%5OL\_P#S]M_WPO\ A1]GG_Y^V_[X7_"@"S15;[//
M_P _;?\ ?"_X4?9Y_P#G[;_OA?\ "@"S15;[//\ \_;?]\+_ (4?9Y_^?MO^
M^%_PH LT56^SS_\ /VW_ 'PO^%'V>?\ Y^V_[X7_  H LT56^SS_ //VW_?"
M_P"%'V>?_G[;_OA?\* +-%5OL\__ #]M_P!\+_A1]GG_ .?MO^^%_P * +-%
M5OL\_P#S]M_WPO\ A1]GG_Y^V_[X7_"@"S15;[//_P _;?\ ?"_X4?9Y_P#G
M[;_OA?\ "@"S15;[//\ \_;?]\+_ (4?9Y_^?MO^^%_PH LT56^SS_\ /VW_
M 'PO^%'V>?\ Y^V_[X7_  H LT56^SS_ //VW_?"_P"%'V>?_G[;_OA?\* +
M-%5OL\__ #]M_P!\+_A1]GG_ .?MO^^%_P * +-%5OL\_P#S]M_WPO\ A1]G
MG_Y^V_[X7_"@"S15;[//_P _;?\ ?"_X4?9Y_P#G[;_OA?\ "@"S15;[//\
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MT'_D+Z__ -?2?^BDHHT'_D+Z_P#]?2?^BDHH D\'_P#(LZ;_ -<16Q6/X/\
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M^_3?X4?;T_YY3?\ ?IO\*M44 5?MZ?\ /*;_ +]-_A1]O3_GE-_WZ;_"K5%
M%7[>G_/*;_OTW^%'V]/^>4W_ 'Z;_"K5% %7[>G_ #RF_P"_3?X4?;T_YY3?
M]^F_PJU10!5^WI_SRF_[]-_A1]O3_GE-_P!^F_PJU10!5^WI_P \IO\ OTW^
M%'V]/^>4W_?IO\*M44 5?MZ?\\IO^_3?X4?;T_YY3?\ ?IO\*M44 5?MZ?\
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M%'V]/^>4W_?IO\*M44 5?MZ?\\IO^_3?X4?;T_YY3?\ ?IO\*M44 5?MZ?\
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M5=/_ -7-_P!=7_G5JJNG_P"KF_ZZO_.@"U1110 4444 %%%% !1110 4444
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MXC>%?!\;/K?B32M)"C)%W>1QM^1.37DOB;]N;X/>&]RIXCDUF1?X-*M))O\
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MHH K?8V_Y^9_^^A_A1]C;_GYG_[Z'^%6:* *WV-O^?F?_OH?X4?8V_Y^9_\
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MN" >A,DFR/\ 0UNJ%1ZM6]3%UH]'<^XOL9_Y^9O^^A_A7">-/C5\/_AZK?\
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M_P!]#_"C[&W_ #\S_P#?0_PJS10!6^QM_P _,_\ WT/\*/L;?\_,_P#WT/\
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M%_Z^-4_].-S7U97RG_P2[_Y,G\"_]?&J?^G&YKZLK0Y HHHH **** ,/0?\
MD+Z__P!?2?\ HI**-!_Y"^O_ /7TG_HI** )/!__ "+.F_\ 7$5L5C^#_P#D
M6=-_ZXBMB@#YA\8?$7]DO1/B'KF@>*A\-++Q-9D3:@VJV%DK^<[-N5G=.905
MW,#R-ZD]:]P^$OB'PSXK^'6AZMX,M(K+PM=0E]/A@M1;1^4'8!DC  "M@L".
M""".M?,_[2GC^U\)?'B:QN/'<GPNCDT*UG75-+\%?VW-J3&:<-'-(T$HC\O
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M )]I_P#OD?XT 6J*J_;3_P ^T_\ WR/\:/MI_P"?:?\ [Y'^- %JBJOVT_\
M/M/_ -\C_&C[:?\ GVG_ .^1_C0!:HJK]M/_ #[3_P#?(_QH^VG_ )]I_P#O
MD?XT 6J*J_;3_P ^T_\ WR/\:/MI_P"?:?\ [Y'^- %JBJOVT_\ /M/_ -\C
M_&C[:?\ GVG_ .^1_C0!:HJK]M/_ #[3_P#?(_QH^VG_ )]I_P#OD?XT 6J*
MJ_;3_P ^T_\ WR/\:/MI_P"?:?\ [Y'^- %JBJOVT_\ /M/_ -\C_&C[:?\
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M7Y?%GAN[TSQ-JETM_J>LWE_;W+:G<,@4[%A)$44:HB)&>B@=3N) /9:JZ?\
MZN;_ *ZO_.IYHA,NTLR\YRC$&J%E9JR2_O9A^]8<2'UH TJ*K?85_P">L_\
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M1 6RO"D#NWH#7S'=?\%0]$FA%KHOPRU6^B ")#/?JJ8'0;$1@,<<567_ (*
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MJWV%?^>L_P#W]:C["O\ SUG_ ._K4 6:*K?85_YZS_\ ?UJ/L*_\]9_^_K4
M6:*K?85_YZS_ /?UJ/L*_P#/6?\ [^M0!9HID48B3:&9O=CDT^@ HHHH ***
M* "BBB@##T'_ )"^O_\ 7TG_ **2BC0?^0OK_P#U])_Z*2B@"3P?_P BSIO_
M %Q%;%8_@_\ Y%G3?^N(K8H ^7?CKX-_9K\$ZAHL/Q-\0GP]>?96BL8;GQ=J
M5J[PB1G)VQW(W?/(WS,">V<* /<?@^WA)OAKH!\"7HU'PCY!_LZZ6\ENQ)'N
M;GS969W^;=RS$U\R_&GXEV^A_%9/%WAGXE2>#WUK0[>UFL[SX7ZKK?GI#<7
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M&L>*+S19C-82W4R6VTD@E3M<[E)53M8$<5]>:/\ L@_!G0RIM?ASH;,O1KF
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!_=;_OMO\:/[.@_NM_WVW^-6:* *W]G0?W6_[[;_ !H_LZ#^ZW_?;?XU9HH
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M#:E]CCA=D2%2/OR ;58@@A"=Q!SC!% '<4444 %%%% &'H/_ "%]?_Z^D_\
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M3P3X7U*.?1GLH[>6#4+[85%_<.9@R10[VV1A2Q;+G[JK7)>#?@3\5_!OQ_\
M FMZC=^'=>T]9-<O-;URVM)XIY9+HV^T2!I2-VR)(XPHVHL)!'(KZXHH ***
M* "BBB@##T'_ )"^O_\ 7TG_ **2BC0?^0OK_P#U])_Z*2B@"3P?_P BSIO_
M %Q%;%8_@_\ Y%G3?^N(K8H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!XU\2-<\2>!?CL-;\9ZMXGTWX<SW.G6^B:AX>GC_ +-M)6*QR0:G#M+XEF8
M2X*@,HRA&3TNE?M%WFH:3X1O'T&*-M<\<7OA!T^TD^2D#WBB<';RQ^R#Y>,;
MSSQ76:Y\ ?!GB3QB/$FIV=]>77VF*]:QEU.Y-A)<18\J9K7S/)+KM4@E>J@]
M1FJEO^S5\/K7QM'XJCT>8:K#J<FM6ZF_N#;6][(&$L\<&_RT>3>VXA?F)R:
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M.Z-\#<ASPV.1@U?JCH>AV'AG1;#2-*M([#3+"!+:UM85PD42*%1%'H  *O4
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M'2;Y_$]F;#5(TEM;N,.\)1W\M&>15*Q O\O[PKR".H.. M_@/XBT'5/".O\
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M* #_ (3WP[_T&;/_ +^BC_A/?#O_ $&;/_OZ*** #_A/?#O_ $&;/_OZ*/\
MA/?#O_09L_\ OZ*** #_ (3WP[_T&;/_ +^BC_A/?#O_ $&;/_OZ*** #_A/
M?#O_ $&;/_OZ*/\ A/?#O_09L_\ OZ*** #_ (3WP[_T&;/_ +^BC_A/?#O_
M $&;/_OZ*** #_A/?#O_ $&;/_OZ*/\ A/?#O_09L_\ OZ*** #_ (3WP[_T
M&;/_ +^BC_A/?#O_ $&;/_OZ*** #_A/?#O_ $&;/_OZ*/\ A/?#O_09L_\
MOZ*** #_ (3WP[_T&;/_ +^BC_A/?#O_ $&;/_OZ*** #_A/?#O_ $&;/_OZ
M*/\ A/?#O_09L_\ OZ*** #_ (3WP[_T&;/_ +^BC_A/?#O_ $&;/_OZ***
M#_A/?#O_ $&;/_OZ*/\ A/?#O_09L_\ OZ*** #_ (3WP[_T&;/_ +^BC_A/
M?#O_ $&;/_OZ*** #_A/?#O_ $&;/_OZ*/\ A/?#O_09L_\ OZ*** #_ (3W
MP[_T&;/_ +^BC_A/?#O_ $&;/_OZ*** #_A/?#O_ $&;/_OZ*/\ A/?#O_09
ML_\ OZ*** #_ (3WP[_T&;/_ +^BC_A/?#O_ $&;/_OZ*** #_A/?#O_ $&;
M/_OZ*/\ A/?#O_09L_\ OZ*** #_ (3WP[_T&;/_ +^BC_A/?#O_ $&;/_OZ
M*** #_A/?#O_ $&;/_OZ*/\ A/?#O_09L_\ OZ*** #_ (3WP[_T&;/_ +^B
MC_A/?#O_ $&;/_OZ*** #_A/?#O_ $&;/_OZ*/\ A/?#O_09L_\ OZ*** #_
M (3WP[_T&;/_ +^BC_A/?#O_ $&;/_OZ*** #_A/?#O_ $&;/_OZ*/\ A/?#
MO_09L_\ OZ*** #_ (3WP[_T&;/_ +^BIAXQT4\C4H"/]ZBB@ _X3#1?^@C!
M^='_  F&B_\ 01@_.BB@ _X3#1?^@C!^='_"8:+_ -!&#\Z** #_ (3#1?\
MH(P?G2_\)AHO_02@_P"^J** #_A,-%_Z"4'_ 'U1_P )AHO_ $$H/^^J** *
:WA>ZAOM0UV>WD66%[I=KKT/[I!1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "9 I(# 2(  A$! Q$!_\0
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MXT?\/!/C1_T%])_\%2?XU\Y44>WJ_P S#^S,#_SYC]R/HW_AX)\:/^@OI/\
MX*D_QH_X>"?&C_H+Z3_X*D_QKYRHH]O5_F8?V9@?^?,?N1]&_P##P3XT?]!?
M2?\ P5)_C1_P\$^-'_07TG_P5)_C7SE11[>K_,P_LS _\^8_<CZ-_P"'@GQH
M_P"@OI/_ (*D_P :/^'@GQH_Z"^D_P#@J3_&OG*BCV]7^9A_9F!_Y\Q^Y'T;
M_P /!/C1_P!!?2?_  5)_C1_P\$^-'_07TG_ ,%2?XU\Y44>WJ_S,/[,P/\
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M2.5 ^4\FA5*TMFPG@LMIM*=."OILCNO^'@GQH_Z"^D_^"I/\:/\ AX)\:/\
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M]?[P_.@#L_@Q_P E@\#_ /8;L_\ T<M2?'#_ )+5X_\ ^P_??^CWJ'X,.O\
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M*/\ A3GP0_Z%'P__ . 8_P *S**.6/9![6O_ ,_)?>S3_P"%.?!#_H4?#_\
MX!C_  H_X4Y\$/\ H4?#_P#X!C_"LRBCECV0>UK_ //R7WLT_P#A3GP0_P"A
M1\/_ /@&/\*/^%.?!#_H4?#_ /X!C_"LRBCECV0>UK_\_)?>S3_X4Y\$/^A1
M\/\ _@&/\*/^%.?!#_H4?#__ (!C_"LRBCECV0>UK_\ /R7WLT_^%.?!#_H4
M?#__ (!C_"C_ (4Y\$/^A1\/_P#@&/\ "LRBCECV0>UK_P#/R7WLT_\ A3GP
M0_Z%'P__ . 8_P */^%.?!#_ *%'P_\ ^ 8_PK,HHY8]D'M:_P#S\E][-/\
MX4Y\$/\ H4?#_P#X!C_"C_A3GP0_Z%'P_P#^ 8_PK,HHY8]D'M:__/R7WLT_
M^%.?!#_H4?#_ /X!C_"C_A3GP0_Z%'P__P" 8_PK,HHY8]D'M:__ #\E][-/
M_A3GP0_Z%'P__P" 8_PH_P"%.?!#_H4?#_\ X!C_  K,HHY8]D'M:_\ S\E]
M[-/_ (4Y\$/^A1\/_P#@&/\ "C_A3GP0_P"A1\/_ /@&/\*S**.6/9![6O\
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M:U+_ )%C1O\ ?F_F*Q:VM2_Y%C1O]^;^8H)>Z,6BBB@H**** "BBB@ HHHH
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M'[/'B2/P?^P/>:Y+I2Z]%86>M3OI;@E;H"[N,QMCG:>_MFO/KGPC/\(_A/\
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MW_",Z+Z7G_?8_P */^$9T7TO/^^Q_A18/:(XFBNV_P"$9T7TO/\ OL?X4?\
M",Z+Z7G_ 'V/\*+![1'$T5VW_",Z+Z7G_?8_PH_X1G1?2\_[['^%%@]HCB:*
M[;_A&=%]+S_OL?X4?\(SHOI>?]]C_"BP>T1Q-%=M_P (SHOI>?\ ?8_PH_X1
MG1?2\_[['^%%@]HCB:*[;_A&=%]+S_OL?X4?\(SHOI>?]]C_  HL'M$<MHO_
M "&+'_KNG\Q2ZY_R&]0_Z^)/_0C77V/AW2(;ZWDC%UO612NYQC.>_%+J'AW2
M)K^YDD%UYC2,S;7&,D\XXHL3SJYP-%=M_P (SHOI>?\ ?8_PH_X1G1?2\_[[
M'^%%BO:(XFBNV_X1G1?2\_[['^%'_",Z+Z7G_?8_PHL'M$<317;?\(SHOI>?
M]]C_  H_X1G1?2\_[['^%%@]HCB:*[;_ (1G1?2\_P"^Q_A1_P (SHOI>?\
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ML?80QRQ!&>*!L^]])UK3O$%A'?:5J%IJEC)D)=6-PD\3X.#AT)!P>.#7SO\
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M%<S=?MT>#;%=2O)O"GC,>'-'U672-9\2)I0;3M,E2;RMTL@?+*S$'Y Q (W
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M+)<P-UB,KNSJA_NJP&>:N_$#]G#X9_%2QT>U\5>#K'5X]'@6UL)':2*6"%0
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M5]%^%OA#3->U6WUS6K33+>WN]3M)3+%<R*@4R*^!N!QUQS7PW\=EM?BY\/\
MXO\ C/PK\'OA[8:)IMU?V=WXT\4WACUJ>\MSMDEMO+4M&X91L5G&>.,$BOT&
MTG2K+0=+M--TVTAL-/LXEAM[6W0)'%&HPJJHX  [5Y;XA_9'^#GBSQ-JOB#5
M_A]I5]JVJ*XO9I#($F+##.8PX0.?[X4-GG.:!L\6T#X9>"_B#^U)X4;Q5X4T
M+Q%/J/PLM=1G_M?3X9VN;D3QJ9V#J=T@3Y=W4#CI7T%^T.BQ_L]_$A$4(B^&
M[]551@ "W< "F>/_ -G/X:_%*QT.U\4^$K/5XM#B$&G,TLL4EM$  (Q)&ZL5
MP!\I)!QGK7;:UX=TWQ%X=O="U*U6[TB]M6LKBU8D+)"R[&0D$'!7C@YH ^1]
M!_9Q\1>++SX:W>CRV\/PU\7:#H=QXXM-X266:QAC>W*#.6\X;(Y, _+'SVKR
MO31!J>BQZ!K<OD^!M;^/>IV?B"-I#'!/#F1HH9FXQ&TBJ""0#@"OT1T72;/P
M[I-AI>FP+::?801VUM I)$4:*%1022>  .?2N2_X4;X!/A7Q!X:D\*V%QH/B
M"^EU/5+"X#2QW-U*VYYCN)*L6P05Q@CC% 6/E7XP^$O#OPN^,7Q$\/> --LM
M TC4OA/JMYXAT31X5BLXYD8K;3-$GRQR,&8=!N'/-2:M\'O!7PW^#_[.OBSP
MMX:T_0?%!USP]YFM6<6V\F6XC F227[SJP8_*Q('8#%?3'@O]G/X:?#SPOKG
MAWP[X0L=,TG7(6M]3C1Y'DO(V4J4DE=C(5PQ &[C)QBN@U'X9^%]6\/Z#H=Y
MH\4^DZ#-;7&F6K.X6VDMP! RD-D[,#&2??- K'SQ\"?A)X#7XL?M#ZBO@WP\
M-7T7Q8QTZZ&FP_:+%6L(WS$VW=&"[,WRXR237C5A\'?!.A_\$]/#?CVP\,Z?
M:>.(?L>I1>(XX_\ 3XYQJ 7*S'YE7;QL!VX[5]HZU^S[\._$7Q(M_']_X5M9
M?&,&"NK1R2Q2,0I4%U1PKD D992<?2M!O@[X,;X:P?#XZ! ?!D*)''I'F2>6
MJK)YBC=NW</\WWJ!V.P\T"$2RNJC8'=V( '&22>PKYLU\7'[8'C72M-TI'C^
M#'A?5H[_ %#6N1_PD=_ V8[:U];>-QN>7HS* N<$U]&WVGV^IZ=<V%U$)K.Y
MA:WEB)(#QLI5EXYY!(KPB']@?X!6QC,7P[@B\LY14U2^ 7G/ \_'6@#@OBC\
M,OCC8?$#XF>/K6V^'_B.RNM+NK+2I]=OKV.ZTC3/);S(;>*.+RUD?EF;)+'
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M  CMK_>D_P"^A_A6I10',S+_ .$=M?[TG_?0_P */^$=M?[TG_?0_P *U**
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MPCMK_>D_[Z'^%:E% <S,O_A';7^])_WT/\*/^$=M?[TG_?0_PK4HH#F9E_\
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0_,<^G^%7:*!784444"/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !* 'D# 2(  A$! Q$!_\0
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:T444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
